A prospective evaluation of fatty pancreas by using EUS

Area of Science:

• Gastroenterology
• Hepatology
• Metabolic Diseases

Background:

• Fatty pancreas pathophysiology is poorly understood.
• Fatty liver is linked to obesity, diabetes, hyperlipidemia, and metabolic syndrome.
• Fatty pancreas may be closely related to fatty liver disease.

Purpose of the Study:

• Determine the prevalence of fatty pancreas.
• Identify risk factors associated with fatty pancreas development.

Main Methods:

• Prospective, single-center study at a tertiary-care academic medical center.
• 250 consecutive patients referred for endoscopic ultrasound (EUS) examination were enrolled.
• Pancreatic echogenicity was graded using a standardized scheme; data on demographics, lifestyle, and comorbidities were collected.

Main Results:

• Prevalence of fatty pancreas was 27.8%.
• Factors associated with fatty pancreas included increased BMI, fatty liver, hyperlipidemia, and metabolic syndrome.
• Multivariate analysis revealed independent associations with increasing BMI and fatty liver.

Conclusions:

• Fatty pancreas is significantly associated with the metabolic syndrome.
• Fatty liver is a key risk factor for fatty pancreas.
• Further research is needed to confirm findings due to study limitations.